CODEX: Choose CODEX for a cutting-edge future in the Ethereum blockchain and beyond!
08 janv. 2024 18h00 HE
|
CODEX
Madrid, Spain, Jan. 08, 2024 (GLOBE NEWSWIRE) -- In the ever-expanding world of cryptocurrencies, CODEX emerges as a game-changer, offering a suite of services that redefine how we engage with...
Codex DNA and RNAimmune Announce Collaboration to Optimize Development of Future mRNA Synthesis and Delivery Kits
22 nov. 2021 08h03 HE
|
Codex
San Diego, CA, Nov. 22, 2021 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (Nasdaq: DNAY), a pioneer in automated benchtop synthetic biology systems, and RNAimmune, a leading biotech company with expertise in...
MEDIA ALERT: Codex DNA Customer to Highlight Advantages of Automated BioXp™ System in Precision Cancer Immunotherapy Applications at 13th Annual PEGS Europe Protein and Antibody Engineering Summit
01 nov. 2021 08h03 HE
|
Codex
San Diego, CA, Nov. 01, 2021 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (Nasdaq: DNAY), a pioneer in automated benchtop synthetic biology systems, today announced that one of its customers will be...
Codex DNA Releases Full-Length Synthetic Genome for Highly Infectious SARS-CoV-2 Delta Variant
01 sept. 2021 16h15 HE
|
Codex
San Diego, CA, Sept. 01, 2021 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (NASDAQ: DNAY), a pioneer in automated benchtop synthetic biology systems, today announced the release of its first full-length...
Codex DNA Releases Long Gene Fragment Cloning On The BioXp™ System
04 mai 2021 10h00 HE
|
Codex
San Diego, CA, May 04, 2021 (GLOBE NEWSWIRE) -- Codex DNA, Inc., creators of the BioXp™ system, a fully automated benchtop instrument that enables numerous synthetic biology workflows, announced the...
Codex DNA Expands End-to-End Automated Synthetic Biology Workstation Enabling High Throughput Synthesis from DNA Sequence to Biologically Active mRNA
27 avr. 2021 10h00 HE
|
Codex
San Diego, CA, April 27, 2021 (GLOBE NEWSWIRE) -- Codex DNA, Inc., creators of the BioXp™ system, a fully automated benchtop instrument that enables numerous synthetic biology workflows, today...
Codex DNA Releases World’s First Synthetic Genomes for Emerging SARS-CoV-2 Variants
10 mars 2021 10h00 HE
|
Codex
San Diego, March 10, 2021 (GLOBE NEWSWIRE) -- Codex DNA, Inc., today announced the release of the world’s first full-length synthetic genomes for two emerging variants of the SARS-CoV-2 virus. The...
Codex DNA Releases New Synthetic Genomes for the Fight Against COVID-19
01 déc. 2020 10h15 HE
|
Codex
San Diego, Dec. 01, 2020 (GLOBE NEWSWIRE) -- Codex DNA, Inc. today announced the release of seven new synthetic SARS-CoV-2 genomes for use in the development of vaccines, therapeutics, and...
Codex DNA Demonstrates Momentum Toward Mission of Building World’s First Vaccine Printer and Global Vaccine Network
25 août 2020 10h24 HE
|
Codex
San Diego, Aug. 25, 2020 (GLOBE NEWSWIRE) -- Codex DNA, Inc., creators of the world’s first fully automated system for high-throughput writing of DNA, today announced critical advancements in its...
Codex DNA Launches New Automated Synthetic Biology Workstation for Commercial Use
18 août 2020 09h15 HE
|
Codex
San Diego, Aug. 18, 2020 (GLOBE NEWSWIRE) -- The new BioXp™ 3250 system – a fully automated, benchtop platform for synthetic biology workflows – dramatically accelerates the development of critical...